Loading chat...

AZ SB1460

Bill

Status

Introduced

2/1/2023

Primary Sponsor

Thomas Shope

Click for details

Origin

Senate

Fifty-sixth Legislature - First Regular Session (2023)

AI Summary

  • Pharmacists may independently order and conduct testing for influenza, respiratory infections, and conditions related to public health threats identified by the Department of Health Services.

  • Pharmacists may initiate and perform treatment for eligible persons who test positive for these conditions, using evidence-based clinical guidelines from the CDC or Infectious Diseases Society of America.

  • Testing must be conducted at a pharmacy or facility with a Certificate of Waiver from the Centers for Medicare and Medicaid Services under the Clinical Laboratory Improvement Amendments.

  • Eligible patients must meet inclusion/exclusion criteria and explicit medical referral criteria specified in current clinical guidelines or evidence-based research.

  • Patients ineligible for pharmacist treatment or who do not respond to initial treatment must be referred to their primary care provider.

Legislative Description

Pharmacists; independent testing; treatment; requirements

Pharmacists

Last Action

Senate read second time

2/2/2023

Committee Referrals

Rules2/1/2023
Commerce2/1/2023

Full Bill Text

No bill text available